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Abstract
About 57% of the total number of cancer cases occur in low and middle income countries. Radiotherapy is one of the main components of cancer treatment and
requires substantial initial investment in infrastructure and training. Many departments continue to have basic facilities and to use simple techniques, while
modern technologies have only been installed in big cities in upper-middle income countries. More than 50% of cancer patients requiring radiotherapy in low
and middle income countries lack access to treatment. The situation is dramatic in low income countries, where the proportion is higher than 90%. The overall
number of additional teletherapy units needed corresponds to about twice the installed capacity in Europe. The ﬁgures for different income level groups clearly
show the correlation between gross national income per capita and the availability of services. The range of radiotherapy needs currently covered varies from 0%
and 3e4% in low income countries in Latin America and Africa up to 59e79% in upper-middle income countries in Europe and Central Asia. The number of
additional radiation oncologists, medical physicist, dosimetrists and radiation therapists (RTTs) required to operate additional radiotherapy departments needed
is 43 200 professionals. Training and education programmes are not available in every developing country and in many cases the only option is sending trainees
abroad, which is not a cost-effective solution. The implementation of adequate local training should be the following step after establishing the ﬁrst radio-
therapy facility in any country. Joint efforts should be made to establish at least one radiotherapy facility in countries where they do not exist, in order to create
radiotherapy communities that could be the base for future expansion.
 2014 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).
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cer cases per country and per region, and the number of
cancer cases for each cancer site were obtained from GLO-
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About 57% of the cancer cases worldwide occur in low
and middle income countries (LMIC) according to GLOBO-
CAN 2012 [1]. Radiotherapy is one of the main components
of modern cancer treatment and requires substantial capital
investment, trained professionals in several disciplines,
high precision equipment and a particular external and
internal organisational structure. Most of the indications for
radiotherapy are related to cancer treatment and it is not
possible to set up a cancer control programme if radio-
therapy is not available. Radiotherapy has experienced a
fast technological advance in the last two decades, which
has improved precision in treatment planning and delivery.d. This is an open access article under the CC BY-NC-ND license (http://
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improved precision require increased quality assurance
needed to provide treatments safely. All these de-
velopments have been quickly implemented in developed
countries at a full scale. Traditional two-dimensional
radiotherapy has been replaced by three-dimensional
conformal radiotherapy, intensity-modulated radiotherapy
and image-guided radiotherapy. The remaining cobalt tel-
etherapy machines have been largely replaced by linear
accelerators (LINAC) with multileaf collimators and image
guidance, capable of delivering intensity-modulated radio-
therapy and volumetric modulated arc therapy. Today, co-
balt machines represent only 7% of the external beam
radiotherapy (EBRT) equipment in high income countries
(HIC). The estimated demand for radiotherapy in developed
countries and regions is in general supplied.
Several analyses of radiotherapy resources in LMIC at the
regional level have been published [2e11]. When published,
these reports were essential to understand the situation in
developing countries and to present reference sources for
comparison when carrying out new analyses.
This article gives an overview of the demand for radio-
therapy in LMIC, with additional detail for different world
regions, but it does not aim to make future projections. It
presents a summary of the most relevant indicators used to
calculate the number of machines needed, with an alterna-
tive one based on the number of fractions per machine. The
problem of stafﬁng and training in LMIC is also discussed.Estimating the Need for Radiotherapy
Data Sources
Economies were classiﬁed according to the deﬁnitions of
theWorld Bank for the current 2015 ﬁscal year. The list from
theWorld Bank includes 214 economies, of which 139 are in
the category of LMIC [12].
LMIC were grouped into regions, deﬁned as per the di-
vision used by the International Atomic Energy Agency
(IAEA) Technical Cooperation Department. Europe and
Central Asia include LMIC from Europe and the post-Soviet
countries in Asia. Asia and the Paciﬁc refers to LMIC from
the rest of Asia and Oceania. The other two regions are Af-
rica and Latin America.
The number of existing machines was primarily obtained
from the IAEA Directory of Radiotherapy Centres (DIRAC) as
of December 2013, with the addition of Kosovo, South
Sudan and the West Bank and Gaza and a minor correction
of data in some countries [13].
The population and the number of cancer cases per re-
gion and country were taken from GLOBOCAN 2012, which
presents data from 184 countries [1].
From the 139 LMIC on the World Bank list of economies,
15 small countries not reported by DIRAC or GLOBCANwere
excluded from the analysis. The ﬁnal number of countries
included was 124, divided in 35 low income countries (LIC),
44 lower-middle income countries (L-MIC) and 45 upper-
middle income countries (U-MIC).Radiotherapy Utilisation (RTU) Calculation
A different RTU rate and the average number of fractions
per radiotherapy course were obtained for each region us-
ing data from GLOBOCAN 2012 and the methodology and
RTU factors for different cancer sites published by the
Collaboration for Cancer Outcomes Research and Evaluation
(CCORE) in their reports [14e16]. A retreatment rate of 25%
was used with 3.3 fractions per course [16e18]. The optimal
RTU tree for cervix cancer was the only one modiﬁed, and a
detailed explanation is given in the brachytherapy section.
The calculated RTU rates and the average number of frac-
tions per course were 0.543 and 16.44 for Africa, 0.533 and
16.53 for Latin America, 0.501 and 15.95 for EuropeeCentral
Asia and 0.495 and 16.29 for AsiaePaciﬁc. Each set of factors
was used to calculate the radiotherapy cases and the frac-
tions for each country in each region.Calculating and Reporting Radiotherapy Equipment
Availability
A commonly used indicator for radiotherapy equipment
availability is the number of teletherapy or megavoltage
units per million population. It only needs a simple calcu-
lation based on easily available data, but it does not account
for differences in cancer incidence and machine
throughput. It will only be used in this overview for com-
parisons with old reports.
A benchmark of between 400 and 500 patients per
treatment unit per year has been used to calculate machine
throughput in several reports [11,19,20]. This benchmark
does not make a distinction between long and short treat-
ments and the assigned proportion of retreatments makes a
big difference in the ﬁnal results. The use of the average
number of fractions for each cancer type, which in the end
gives an average number of fractions for all cancer cases or
treatment courses, is a step forward in terms of accuracy in
the results. As the number of fractions in cases needing a
second radiotherapy course is small, the relative weight of
retreatments is smaller andmore realistic [16]. This method
makes the comparison between different operating hours
on the machines easier. The benchmark of 450 patients per
machine correlated well with the calculation based on
average fractions, 25% of retreatment and 8 operating hours.
Some developed countries, like Canada and the UK, use
extended working days or extended weeks to decrease
waiting times. Cancer Care Ontario, in its report on Radia-
tion Treatment Capital Investment Strategy from April 2012,
recommends extending the treatment day to 12 h in larger
centres and on 50% of the machines in smaller centres and
to 10 h on the remaining 50% of machines [21].
The benchmark of 450 patients per machine, which
corresponds to about 8 operating hours per day, seems
adequate for HIC. For scenarios where radiotherapy demand
is not satisﬁed, a treatment day of 10 h optimises the uti-
lisation of equipment and decreases the number of ma-
chines needed. The working day could even be extended,
but difﬁculties with transportation and auxiliary services at
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beyond 12 h [21].
There are many very well-structured reports on planning
radiotherapy services at national or provincial levels in
several countries, particularly Australia, Canada and the UK.
These reports, publicly available, are an excellent source of
information and should be used as a model for planning by
LMIC [19e24].
Optimal Versus Actual Radiotherapy Utilisation
When the demand for radiotherapy is supplied, the pro-
portion of different cancers treated and the total number of
patients receiving radiotherapy (actual RTU) should coincide
with calculations of optimal RTU. Currently, there are no data
on actual RTU in LMIC, where the demand for radiotherapy is
not satisﬁed. The IAEA is conducting a study in nine selected
MIC representing the four regions to estimate their optimal
and actual RTU. The logical assumption should be that in LIC
and L-MIC cancer cases will be diagnosed at more advanced
stages, when they become symptomatic, that surgery will
play a smaller role and a higher proportion of cases will need
radiotherapy. The proportion of short palliative radiotherapy
courses should also be higher than in HIC or U-MIC. The
calculation of the number ofmachines needed based on how
many fractions can be delivered per machine per year
divided by the number of fractions per patient is preferable
to using 450 patients per machine for this scenario.
A benchmarking exercise carried out in Zambia is a good
example of actual RTU being different from optimal RTU.
The calculated proportion for the top ﬁve cancers requiring
radiotherapy (using the modiﬁed tree for cervical cancer)
were 32.8% for cervix, 11.9% for breast, 7.1% for Kaposi sar-
coma, 6.9% for oesophagus and 5.7% for prostate. The
radiotherapy centre treats 1152 patients (24 534 fractions)
per year with one telecobalt machine (540 patients; 11 070
fractions/year) and one LINAC (612 patients; 13 464 frac-
tions/year). The average number of fractions per patient is
21.3. The explanation for the relatively high ﬁgure of 21.3 is
that cervix patients represent 48% (556/year) of all cases,
breast 11%, head and neck 9% and prostate 7%. As they are
not using hypofractionated protocols for breast and most
prostate patients having localised disease, 75% of the pa-
tients have treatments of 5 weeks or more.
When radiotherapy demand is not satisﬁed then referral
patterns, decisions to treat policies or preferences and other
factors, such as the geographical distribution of services,
play an important role in determining the actual RTU, which
should be based on a case by case assessment and not on
assumptions.Current Status of Radiotherapy in Low and
Middle Income Countries
There are 4221 installed teletherapy machines in LMIC.
These representbetween38and49%of themachinesneeded,
depending on the benchmark used. Between 4320 and 6958
additional units are required, which corresponds to abouttwice the installed capacity in Europe [9]. The range of needs
currently covered varies from 0% and 3e4% in LIC in Latin
America andAfricaupto59e79% inU-MIC inEuropeeCentral
Asia. The detailed analysis of the status of radiotherapy in
LMIC is shown inTable1. The subdivisionof LMIC inLIC, L-MIC
andU-MICused for the analysis alloweda subsetof indicators
for each income group. The population in LMIC represents
82% of the world’s population and from 187 countries
included inDIRAC,124 are LMIC. Around 5000millionpeople
live equally distributed between L-MIC and U-MIC and 840
million in LIC. However, the number of cancer cases is double
in U-MIC than in L-MIC. There are 39 countries without
radiotherapy services and the correlation between gross na-
tional income per capita and the number of teletherapy ma-
chinesproposedby Levin andTatsuzaki [25] is reﬂected in the
proportion of LIC, L-MIC and U-MIC without radiotherapy.
Thirty-one per cent of teletherapy units are cobalt machines,
compared with 7% in HIC. Each machine serves 1.4 million
people, compared with 0.4 million per machine in HIC. This
information is also presented in the table using two different
benchmarks, the annual number of patients per machine for
an8h treatmentdayand thenumberof fractionspermachine
per year for 10 operating hours. The number of machines
neededwas also calculated using these two benchmarks. The
needs currently covered varied between 38 and 49%
depending on the benchmark used. The subsets of indicators
for different income groups show a similar trend.
A direct comparison between this analysis and the work
published by Barton et al. [2] in 2006 is not possible. Many
variables have changed since then. As an example, eight
previous LMI European countries became HIC, and the
Central Asian countries in our data were not added to
Europe in that analysis. Equipment numbers were taken
from DIRAC in both, but DIRAC included fewer countries at
that time and the numbers are more accurate now.
IAEA invested V 263 million in cancer projects between
1980 and 2012, and this amount only represents about 2.5%
of what would be necessary only to set up the additional
radiotherapy facilities required, excluding training costs.
The IAEA Advisory Group on increasing access to Radio-
therapy Technology in LMIC and the Union for International
Cancer Control (UICC) Global Task Force on Radiotherapy for
Cancer Control are initiatives studying the problem of ac-
cess to radiotherapy in order to develop strategies to
improve the current situation.
Africa
Africa includes 51 LMIC and is the regionwith the largest
proportion of LIC and the lowest access to radiotherapy.
About 72% of the people in Sub-Saharan Africa live with less
than $2 per day. The region is overwhelmed by many basic
problems like infant mortality, infectious diseases and
infrastructure needs, which are more urgent priorities than
cancer care. Between 1991 and 2010 the number of cases
with indication of radiotherapy increased 239% and the
number of machines increased 286% [2e5,8]. The propor-
tion of teletherapy machines per million people has
improved from 0.184 to 0.260 since 1998 [2,5].
Table 1
Data and calculations relevant to external beam radiotherapy in low and middle income countries (LMIC)
LMIC Total LIC L-MIC U-MIC
Number of countries 124 35 44 45
Population (million) A 5761.0 837.8 2525.2 2398.1
% 100% 14% 44% 42%
New cancer cases/year B 7 964 367 675 500 2 358 267 4930 600
Number of radiotherapy courses/year C ¼ B  0.5053  1.25* 5 030 353 439 981 1 482 826 3107 546
Number of radiotherapy fractions/year D ¼ C  16.31 81 991 583 7 202 258 24 153 656 50 707 313
% of countries without radiotherapy 31% 66% 27% 9%
Number of existing machines E 4221 62 1014 3145
Number of LINAC F 2919 25 523 2371
Number of Co60 machines G 1302 37 491 774
% of Co60 machines G/E 31% 60% 48% 25%
Machines/million population E/A 0.733 0.074 0.402 1.311
Radiotherapy courses/machine (450/year e 8 h/day) C/E 1192 7096 1462 988
Fractions/machine (9600/year e 10 h/day) D/E 19 425 116 165 23 820 16 123
Total machines needed
(1 x 450 courses/year 8 operating hours/day)
H ¼ C/450 11 179 978 3295 6906
Additional machines needed I ¼ HeE 6958 916 2281 3761
% of needs currently covered E/H 38% 6% 31% 46%
Total machines needed
(1 x 9600 fractions/year 10 operating hours/day)
J ¼ D/9600 8541 750 2516 5282
Additional machines needed K ¼ JeE 4320 688 1502 2137
% of needs currently covered E/J 49% 8% 40% 60%
LIC, low income countries; L-MIC, lower-middle income countries; U-MIC, upper-middle income countries.
* This radiotherapy utilisation rate was obtained retrospectively by dividing the addition of radiotherapy courses for each country by the
number of cancer cases.
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is shown in Table 2. Twenty-eight countries do not have
radiotherapy services, 14 have three or fewer machines and
only seven have more than 10 machines. Cobalt machines
represent 30% of the equipment. There is an average of 3.8
million people per machine, which varies a lot between
different income categories. Between 22 and 28% of the
needs are covered depending on the benchmark used.
Countries without radiotherapy are slowly setting up
their ﬁrst departments. Sustainability is a problem and
expansion is mainly happening in countries with a larger
number of machines.
Latin America
Latin America includes 22 LMIC, of which 14, repre-
senting 89% of the population, are U-MIC. Table 3 summa-
rises the radiotherapy situation. Only two countries lack
radiotherapy facilities. Cobalt machines represent 31% of
the equipment. There is an average of 0.7 million people per
machine. The number of EBRT machines per million popu-
lation has increased from 1.376 to 1.523 in the last 10 years
[2,7]. The needs are satisﬁed between 58 and 75%,
depending on the benchmark used. Recently Brazil pur-
chased 80 LINACS, which represent 23% of their installed
machines and 9% of the installed capacity in Latin America.
Asia and the Paciﬁc
Asia and the Paciﬁc has 30 LMIC. With nearly 4000
million people, it is the most populated region. Only 8% ofthe population lives in LIC. The status of radiotherapy is
presented in Table 4. There are seven countries without
radiotherapy services. The proportion of cobalt machines is
27%. The average population per machine is 1.5 million. The
number of machines per million people in 1999 in 12 Asian
countries was 0.3839 and the actual proportion is 0.661 for
30 countries [2,6]. The needs are covered in 34e45%,
depending on the benchmark used.
Europe and Central Asia
Europe and Central Asia include 21 LMIC, of which only
two are LIC. RTU indicators are presented in Table 5. Two
countries do not have radiotherapy services. Cobalt ma-
chines represent 48% of the equipment, the highest pro-
portion of all regions. Also, 0.5 million people are served per
machine. The proportion of teletherapy machines per
million people in European LMIC reported by Barton et al.
[2] was 1.832 in 1998. The present analysis shows a pro-
portion of 1.951 on a different subset of countries and
Rosenblatt et al. [9] found an average of 5.288 machines per
million people in 33 European countries. RTU supply is
between 55 and 74%, depending on the benchmark used.
The IAEA is conducting a patterns of care study in the re-
gion, with emphasis on radiotherapy quality indicators.
Brachytherapy
DIRAC presents the data on brachytherapy equipment
divided between low dose rate manual afterloading, low
dose rate remote afterloading, high dose rate (HDR) 192Ir
Table 2
Data and calculations relevant to external beam radiotherapy in Africa
Africa Total LIC L-MIC U-MIC
Number of countries 51 26 16 9
Population (million) A 1069.5 510.4 427.3 131.9
% 100% 48% 40% 12%
New cancer cases/year B 843 900 360 600 332 900 150 400
Number of radiotherapy courses/year C ¼ B  0.543  1.25 572 755 244 739 225 939 102 076
Number of radiotherapy fractions/year D ¼ C  16.44 9 415 182 4023 125 3 714 083 1677 975
% of countries without radiotherapy 55% 81% 44% 0%
Number of existing machines E 278 15 136 127
Number of LINAC F 194 7 97 90
Number of Co60 machines G 84 8 39 37
% of Co60 machines G/E 30% 53% 29% 29%
Machines/million population E/A 0.260 0.029 0.318 0.963
Radiotherapy courses/machine (450/year e 8 h/day) C/E 2060 16,316 1661 804
Fractions/machine (9600/year e 10 h/day) D/E 33 868 268 208 27 309 13 212
Total machines needed
(1 x 450 courses/year 8 operating hours/day)
H ¼ C/450 1273 544 502 227
Additional machines needed I ¼ H e E 995 529 366 100
% of needs currently covered E/H 22% 3% 27% 56%
Total machines needed
(1 x 9600 fractions/year 10 operating hours/day)
J ¼ D/9600 981 419 387 175
Additional machines needed K ¼ J e E 703 404 251 48
% of needs currently covered E/J 28% 4% 35% 73%
LIC, low income countries; L-MIC, lower-middle income countries; U-MIC, upper-middle income countries.
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using manual afterloading sets and low dose rate after-
loaders are no longer supported by their manufacturers. For
the purpose of this analysis, only 192Ir- or 60Co-based HDR
machines and only indications for cervical cancer treatment
were considered. Brachytherapy availability is important inTable 3
Data and calculations relevant to external beam radiotherapy in Latin A
Latin America
Number of countries
Population (million) A
%
New cancer cases/year B
Number of radiotherapy courses/year C ¼ B  0.53
Number of radiotherapy fractions/year D ¼ C  16.5
% of countries without radiotherapy
Number of existing machines E
Number of LINAC F
Number of Co60 machines G
% of Co60 machines G/E
Machines/million population E/A
Radiotherapy courses/machine (450/year e 8 h/day) C/E
Fractions/machine (9600/year e 10 h/day) D/E
Total machines needed
(1 x 450 courses/year 8 operating hours/day)
H ¼ C/450
Additional machines needed I ¼ H e E
% of needs currently covered E/H
Total machines needed
(1 x 9600 fractions/year 10 operating hours/day)
J ¼ D/9600
Additional machines needed K ¼ J e E
% of needs currently covered E/J
LIC, low income countries; L-MIC, lower-middle income countries; U-MLMIC because cervical cancer accounts for 7.01% of the pa-
tients with indication of radiotherapy and radical treatment
of this disease, even in its advanced stages, requires the
combination of EBRT and brachytherapy. RTU for EBRT and
brachytherapy in cervix cancer was calculated using the
CCORE optimal RTU tree for cervix, modiﬁed to include 45%merica
Total LIC L-MIC U-MIC
22 1 7 14
574.3 10.3 53.0 511.1
100% 2% 9% 89%
1 018 700 7900 55 200 955 600
27  1.25 678 366 5261 36 758 636 347
6 11 235 760 87 133 608 829 10 539 798
9% 100% 0% 7%
875 0 38 837
606 0 18 588
269 0 20 249
31% e 53% 30%
1.523 0 0.718 1.638
775 e 967 760
12,841 e 16 022 12 592
1507 12 82 1414
632 12 44 577
58% 0% 47% 59%
1170 9 63 1098
295 9 25 261
75% 0% 60% 76%
IC, upper-middle income countries.
Table 4
Data and calculations relevant to external beam radiotherapy in Asia and the Paciﬁc
Asia and the Paciﬁc Total LIC L-MIC U-MIC
Number of countries 30 6 15 9
Population (million) A 3847.0 304.6 1960.6 1581.8
% 100% 8% 51% 41%
New cancer cases/year B 5 416 398 295 700 1 766 798 3353 900
Number of radiotherapy courses/year C ¼ B  0.4949  1.25 3 350 411 182 911 1 092 885 2074 616
Number of radiotherapy fractions/year D ¼ C x 16.29 54 570 598 2 979 199 17 800 617 33 790 783
% of countries without radiotherapy 23% 17% 27% 22%
Number of existing machines E 2541 44 702 1795
Number of LINAC F 1845 18 379 1448
Number of Co60 machines G 696 26 323 347
% of Co60 machines G/E 27% 59% 46% 19%
Machines/million population E/A 0.661 0.144 0.358 1.135
Radiotherapy courses/machine (450/year e 8 h/day) C/E 1319 4157 1557 1156
Fractions/machine (9600/year e 10 h/day) D/E 21 476 67 709 25 357 18 825
Total machines needed
(1 x 450 courses/year 8 operating hours/day)
H ¼ C/450 7445 406 2429 4610
Additional machines needed I ¼ H eE 4904 362 1727 2815
% of needs currently covered E/H 34% 11% 29% 39%
Total machines needed
(1 x 9600 fractions/year 10 operating hours/day)
J ¼ D/9600 5684 310 1854 3520
Additional machines needed K ¼ J e E 3143 266 1152 1725
% of needs currently covered E/J 45% 14% 38% 51%
LIC, low income countries; L-MIC, lower-middle income countries; U-MIC, upper-middle income countries.
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average number of fractions was also calculated [16]. The
EBRT utilisation rate was 85.4%, with an average of 25
fractions per EBRT course, and 71.4% of brachytherapy uti-
lisation, with an average of 2.9 fractions per brachytherapy
course. From the total number of 413 020 cervix cancerTable 5
Data and calculations relevant to external beam radiotherapy in Europ
EuropeeCentral Asia
Number of countries
Population (million) A
%
New cancer cases/year B
Number of radiotherapy courses/year C ¼ B  0.50
Number of radiotherapy fractions/year D ¼ C  15.
% of countries without radiotherapy
Number of existing machines E
Number of LINAC F
Number of Co60 machines G
% of Co60 machines G/E
Machines/million population E/A
Radiotherapy courses/machine (450/year e 8 h/day) C/E
Fractions/machine (9600/year e 10 h/day) D/E
Total machines needed
(1 x 450 courses/year 8 operating hours/day)
H ¼ C/450
Additional machines needed I ¼ H e E
% of needs currently covered E/H
Total machines needed
(1 x 9600 fractions/year 10 operating hours/day)
J ¼ D/9600
Additional machines needed K ¼ J eE
% of needs currently covered E/J
LIC, low income countries; L-MIC, lower-middle income countries; U-Mcases in LMIC, 294 707 require brachytherapy, with 880 133
fractions. 440 HDR machines are needed, assuming that the
procedure takes 1 h and that between eight and nine pro-
cedures are carried out per day. There are 402 available HDR
machines in LMIC. The distribution per region is shown in
Table 6.e and Central Asia
Total LIC L-MIC U-MIC
21 2 6 13
270.1 12.5 84.4 173.3
100% 5% 31% 64%
685 369 11 300 203 369 470 700
05  1.25 428 821 7070 127 244 294 507
95 6 841 686 112 802 2 030 128 4698 756
10% 0% 17% 8%
527 3 138 386
274 0 29 245
253 3 109 141
48% 100% 79% 37%
1.951 0.240 1.636 2.228
814 2357 922 763
12 982 37 601 14 711 12 173
953 16 283 654
426 13 145 268
55% 19% 49% 59%
713 12 211 489
186 9 73 103
74% 26% 65% 79%
IC, upper-middle income countries.
Table 6
Availability of high dose rate (HDR) afterloaders in low and middle
income countries
HDR
available
HDR
needed
Needs
covered
Africa 40 105 38%
Latin America 156 68 228%
Asia-Paciﬁc 108 242 45%
Europe-Central Asia 98 24 407%
Total 402 440 91%
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tral Asia do not need additional brachytherapy afterloaders,
equipment is not uniformly distributed between countries.
Brazil, South Africa and Ukraine have 60, 38 and 37% of all
HDR machines in their regions, although they have 43, 9
and 21% of the radiotherapy patients, respectively. Brachy-
therapy needs and the distribution of brachytherapy re-
sources in LMIC require further detailed analysis.Stafﬁng, Education and Training Needs
Often the analysis of radiotherapy demand is overly
focused on equipment. New radiotherapy departments
require signiﬁcant investment in infrastructure and equip-
ment, but the availability of qualiﬁed professionals to run
these departments can be a difﬁcult problem to solve in
LMIC. Training a radiotherapy team takes years and is
expensive. A detailed calculation on stafﬁng needs in LMIC
is difﬁcult because available data on the number of pro-
fessionals are inaccurate. Where training programmes are
established, new professionals graduate every year and
ﬁgures can change quickly and not be reﬂected if data are
not constantly updated. In some regions multi-employment
is common. DIRAC requests information about full-time
equivalence, but usually only the total numbers are re-
ported, and the number of professionals in those regions
could be overestimated. In countries where clinical oncol-
ogists are also responsible for the administration of
chemotherapy the assessment is more difﬁcult.
The estimation of additional staff needed to operate new
required facilities is possible. Existing guidelines on stafﬁng
levels usually assume 8working hours per day [11,19,20,26].
National regulations in many countries reduce the number
of working hours per day for different professionals. The
following calculation was based on hypothetical facilities
with four EBRT machines, one ﬂuoroscopic or computed
tomography simulator, one treatment planning system
(TPS) and one HDR afterloader, operating 10 h daily, 5 days
per week [27]. A maximum of 2356 patients (38 400 frac-
tions) can be treated annually with EBRT and 643 cervical
cancer cases (1920 fractions) can be treated with HDR
brachytherapy. Each of these departments will require 12
radiation oncologists, six medical physicists, three dosi-
metrists or treatment planners and 19 radiation therapists
(RTTs), all working 8 h per day. If all 4320 additional meg-
avoltage machines required in LMIC are accommodated inthis way, the total number of additional professionals
needed will be 12 960 radiation oncologists, 6480 medical
physicists, 3240 dosimetrists and 20 520 RTTs. Training
costs are less visible in countries where radiotherapy is well
established and training programmes are available. Trainees
demand time from academic staff, but they are part of the
working force and contribute to the activities of the
department. In countries where there are no radiotherapy
facilities or training possibilities, the only solution is to train
professionals abroad. IAEA supports full training overseas of
candidates from LIC and shares the cost in the case of MIC,
trying to use academic institutions within the same region.
The grant includes travel, living expenses and training fees
during the total duration of the training programme. The
cost varies betweenV 50 000 andV 68 000 per professional
per year, depending on the region. Education of a radiation
oncologist costs between V 200 000 and V 272 000 and a
medical physicist or an RTT between V 100 000 and
V 136 000. Training an entire basic team consisting of four
radiation oncologists, three medical physicists and seven
RTTs will cost between V 1850 000 and V 2 516 000. When
establishing the ﬁrst radiotherapy facility in a country,
training abroad cannot be avoided and the budget allocated
for training, construction of the facility and the acquisition
of equipment should be available simultaneously. This is
one of the reasons why radiotherapy is perceived as an
expensive discipline when managers do not realise that a
well-designed building will be functional for 30e40 years,
machines can run for 15 years and trained staff should treat
patients without needing the same high initial investment
in training again. After the initial phase of making the
department fully operational it is essential to begin local
training programmes in order to limit expenditure and
ensure sustainability and future expansion of the services.
This was the strategy used by Zambia, which implemented a
curriculum for RTTs shortly after beginning operation, and
more recently a training programme for radiation oncolo-
gists. In Africa there are only 10 countries where it is
possible to train radiotherapy professionals, and new pro-
grammes are needed.
Professionals working in basic departments will need
additional training when advanced technologies are
installed.Conclusions
More than 50% of patients requiring radiotherapy in
LMIC do not have access to treatment. The situation is
dramatic in LIC, where the proportion is higher than 90%.
Although 4221 teletherapy machines are available in LMIC,
between 4300 and 7000 additional units are needed. This
situation can improve, but still a large proportion of patients
with indication for radiotherapy will not have access to
treatment in the near future. Meanwhile, a possible strategy
is to join efforts to establish at least one radiotherapy facility
in countries where they do not exist, in order to create
radiotherapy communities that could be the base for future
expansion.
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